Publication | Open Access
The myogenesis program drives clonal selection and drug resistance in rhabdomyosarcoma
67
Citations
48
References
2022
Year
Malignant DiseaseOncogenic AgentGeneticsMyogenesis ProgramClonal SelectionMedicineCell BiologyCancer ResearchTumor BiologyDrug Resistance
| Year | Citations | |
|---|---|---|
Page 1
Page 1